P&G Hygiene

₹15729.4 49 | 0.3%

WEBSITE BSE:500459 NSE : PROCTER &GAM 10 May, 16:01

Market Cap ₹51059 Cr.

Stock P/E 68.5

P/B 42.3

Current Price ₹15729.4

Book Value ₹ 371.8

Face Value 10

52W High ₹19086.2

Dividend Yield 1.18%

52W Low ₹ 13391.2

Edit Ratio

P&G Hygiene Research see more...

Overview Inc. Year: 1964Industry: Household & Personal Products

Procter & Gamble Hygiene and Health Care Limited is engaged in the production and promoting of branded packaged FMCG inside the feminine care and healthcare companies. The Company's segments include Healthcare merchandise and Hygiene merchandise. The Healthcare merchandise section consists of ointment and creams, cough drops and tablets. The Hygiene merchandise section consists of feminine hygiene merchandise and different skin care hygiene merchandise. It gives ayurvedic products, sanitary napkins, and deodorants. Its portfolio of manufacturers includes Whisper, Vicks VapoRub, Vicks Throat Drops, Vicks Action 500 Advanced, Vicks Inhaler and Vicks BabyRub. The Company's merchandise are bought thru retail operations inclusive of mass merchandisers, grocery stores, club membership shops, drug shops, branch stores and, high frequency stores. The Company has its manufacturing locations at Goa and Baddi in Himachal Pradesh, aside from third party manufacturing locations spread across India.

P&G Hygiene Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

P&G Hygiene Quarterly Results

#(Fig in Cr.)	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Net Sales	1093	973	776	1045	1137	883	853	1138	1133	1002
Other Income	7	6	6	7	9	14	10	16	16	14
Total Income	1100	979	782	1052	1147	898	863	1154	1149	1016
Total Expenditure	797	808	709	831	847	734	638	853	824	745
Operating Profit	303	171	73	221	300	164	225	301	325	271
Interest	3	7	1	1	4	4	3	2	3	22
Depreciation	13	13	14	14	14	15	15	14	14	15
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	288	151	58	206	282	146	207	284	309	234
Provision for Tax	75	48	15	51	74	-19	55	74	80	80
Profit After Tax	212	103	43	154	207	165	151	211	229	154
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	212	103	43	154	207	165	151	211	229	154
Adjusted Earnings Per Share	65.3	31.7	13.1	47.6	63.9	50.8	46.6	64.9	70.5	47.6

P&G Hygiene Profit & Loss

#(Fig in Cr.)	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	TTM
Net Sales	1687	2051	2334	2275	2320	2455	2947	3002	3574	3901	3918	4126
Other Income	67	80	76	88	79	24	55	44	56	30	45	56
Total Income	1754	2131	2409	2363	2399	2479	3002	3046	3630	3931	3963	4182
Total Expenditure	1437	1630	1850	1670	1658	1840	2339	2398	2706	3077	3054	3060
Operating Profit	318	501	559	693	742	639	663	648	924	854	909	1122
Interest	0	5	6	6	10	5	5	6	6	11	11	30
Depreciation	31	35	53	52	60	52	50	48	48	53	58	58
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Profit Before Tax	286	460	501	636	672	582	607	594	870	790	839	1034
Provision for Tax	83	158	155	213	239	207	188	161	218	214	161	289
Profit After Tax	203	302	346	423	433	375	419	433	652	576	678	745
Adjustments	0	0	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	203	302	346	423	433	375	419	433	652	576	678	745
Adjusted Earnings Per Share	62.6	93	106.6	130.2	133.3	115.4	129.1	133.4	200.8	177.4	208.9	229.6

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	0%	9%	10%	9%
Operating Profit CAGR	6%	12%	7%	11%
PAT CAGR	18%	16%	13%	13%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	15%	5%	9%	16%
ROE Average	85%	80%	66%	50%
ROCE Average	101%	102%	87%	70%

P&G Hygiene Balance Sheet

#(Fig in Cr.)	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023
Shareholder's Funds	805	1003	1229	1652	526	806	909	1158	714	738	946
Minority's Interest	0	0	0	0	0	0	0	0	0	0	0
Borrowings	0	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	-0	-4	-1	-5	25	26	29	46	45	33	41
Total Current Liabilities	441	502	716	511	582	571	642	595	835	860	1085
Total Liabilities	1246	1501	1944	2157	1134	1402	1580	1799	1595	1631	2072
Fixed Assets	215	240	309	317	286	250	234	207	184	164	170
Other Non-Current Assets	191	249	278	208	245	316	256	264	294	332	406
Total Current Assets	841	1012	1357	1632	603	815	1069	1321	1117	1135	1496
Total Assets	1246	1501	1944	2157	1134	1402	1580	1799	1595	1631	2072

P&G Hygiene Cash Flow

#(Fig in Cr.)	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023
Opening Cash & Cash Equivalents	173	161	266	615	1067	102	392	526	884	648	625
Cash Flow from Operating Activities	104	335	426	352	445	415	413	474	863	573	826
Cash Flow from Investing Activities	-32	-135	28	221	149	-19	34	75	7	-27	-10
Cash Flow from Financing Activities	-85	-95	-105	-122	-1559	-106	-314	-190	-1106	-569	-477
Net Cash Inflow / Outflow	-13	105	349	452	-964	290	134	358	-236	-23	339
Closing Cash & Cash Equivalent	161	266	615	1067	102	392	526	884	648	625	964

P&G Hygiene Ratios

#	Jun 2013	Jun 2014	Jun 2015	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023
Earnings Per Share (Rs)	62.61	93.04	106.64	130.16	133.31	115.4	129.12	133.42	200.8	177.37	208.92
CEPS(Rs)	72.25	103.88	122.82	146.08	151.72	131.53	144.46	148.17	215.48	193.66	226.89
DPS(Rs)	25	27.5	30.25	36	389	40	88	105	315	160	185
Book NAV/Share(Rs)	248.1	308.96	378.52	507.78	159.65	244.05	274.67	349.7	210.9	214.95	276.56
Core EBITDA Margin(%)	14.72	20.34	20.49	25.79	27.4	25.06	20.61	20.11	24.28	17.73	18.5
EBIT Margin(%)	16.85	22.53	21.46	27.32	28.2	23.91	20.8	19.98	24.51	17.24	18.22
Pre Tax Margin(%)	16.85	22.27	21.22	27.05	27.77	23.69	20.61	19.78	24.34	17	17.97
PAT Margin (%)	11.96	14.61	14.67	17.99	17.89	15.26	14.22	14.43	18.24	12.39	14.52
Cash Profit Margin (%)	13.81	16.31	16.89	20.18	20.36	17.39	15.91	16.02	19.57	13.52	15.77
ROA(%)	14.99	21.99	20.1	20.6	26.3	29.54	28.1	25.63	38.41	35.7	36.63
ROE(%)	27.05	33.41	31.02	29.37	39.95	57.17	49.79	42.74	71.64	83.3	85.01
ROCE(%)	38.1	51.51	45.4	44.56	62.65	88.18	71.48	58.05	93.58	110.39	101.08
Receivable days	13.86	14.74	15.47	20.48	21.31	20.91	20.43	21.14	15.76	13.13	15.95
Inventory Days	22.69	20.96	18.37	19.15	23	22.37	20.25	24.83	23.2	18.97	17.73
Payable days	119.29	97.67	119.33	143.65	137.09	148.01	140.88	178.06	202.36	179.52	192.14
PER(x)	44.34	45.78	63.52	48.24	60.36	85.8	82.91	76.11	66.38	75.57	68.47
Price/Book(x)	11.19	13.79	17.89	12.37	50.4	40.57	38.98	29.04	63.2	62.36	51.72
Dividend Yield(%)	0.9	0.65	0.45	0.57	4.83	0.4	0.82	1.03	2.36	1.19	1.29
EV/Net Sales(x)	5.24	6.61	9.16	8.49	11.21	12.93	11.61	10.68	11.92	10.99	11.6
EV/Core EBITDA(x)	27.86	27.06	38.22	27.84	35.05	49.64	51.63	49.49	46.13	50.19	49.99
Net Sales Growth(%)	30.01	21.59	13.79	-2.5	1.98	5.81	20.02	1.87	19.06	9.14	0.44
EBIT Growth(%)	28.32	62.72	8.77	26.7	6.3	-13.94	4.38	-2.1	46.01	-8.52	6.18
PAT Growth(%)	12.1	48.62	14.61	22.06	2.42	-13.44	11.89	3.33	50.5	-11.67	17.78
EPS Growth(%)	12.1	48.62	14.61	22.06	2.42	-13.44	11.89	3.33	50.5	-11.67	17.78
Debt/Equity(x)	0	0	0	0	0	0	0	0	0	0	0
Current Ratio(x)	1.91	2.02	1.9	3.19	1.04	1.43	1.66	2.22	1.34	1.32	1.38
Quick Ratio(x)	1.64	1.78	1.73	2.94	0.73	1.21	1.35	1.87	1.04	1.05	1.18
Interest Cover(x)	0	86.4	88.55	102.36	65.47	110.36	111.83	98.84	143.37	71.61	74.77
Total Debt/Mcap(x)	0	0	0	0	0	0	0	0	0	0	0

P&G Hygiene Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	70.64	70.64	70.64	70.64	70.64	70.64	70.64	70.64	70.64	70.64
FII	2.63	2.25	2.03	1.68	1.12	1.05	1.13	1.3	1.48	1.57
DII	13.47	13.89	14.19	14.57	15.28	15.44	15.49	15.44	15.29	15.11
Public	13.26	13.22	13.14	13.12	12.96	12.87	12.74	12.62	12.59	12.68
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	2.29	2.29	2.29	2.29	2.29	2.29	2.29	2.29	2.29	2.29
FII	0.09	0.07	0.07	0.05	0.04	0.03	0.04	0.04	0.05	0.05
DII	0.44	0.45	0.46	0.47	0.5	0.5	0.5	0.5	0.5	0.49
Public	0.43	0.43	0.43	0.43	0.42	0.42	0.41	0.41	0.41	0.41
Others	0	0	0	0	0	0	0	0	0	0
Total	3.25	3.25	3.25	3.25	3.25	3.25	3.25	3.25	3.25	3.25

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 80%
Company is almost debt free.

Cons

Debtor days have increased from 179.52 to 192.14days.
Stock is trading at 42.3 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.